90 related articles for article (PubMed ID: 16750367)
21. Inhibitory effect of linomide on lipopolysaccharide-induced proinflammatory cytokine tumor necrosis factor-alpha production in RAW264.7 macrophages through suppression of NF-kappaB, p38, and JNK activation.
Xiao ZY; Zhou WX; Zhang YX; Cheng JP; He JF; Yang RF; Yun LH
Immunol Lett; 2007 Dec; 114(2):81-5. PubMed ID: 17964662
[TBL] [Abstract][Full Text] [Related]
22. Hydrogen peroxide induces the production of tumor necrosis factor-alpha in RAW 264.7 macrophage cells via activation of p38 and stress-activated protein kinase.
Nakao N; Kurokawa T; Nonami T; Tumurkhuu G; Koide N; Yokochi T
Innate Immun; 2008 Jun; 14(3):190-6. PubMed ID: 18562577
[TBL] [Abstract][Full Text] [Related]
23. SK-126, a synthetic compound, regulates the production of inflammatory cytokines induced by LPS in antigen-presenting cells.
Kang K; Kim H; Kim KI; Yang Y; Yoon DY; Kim JH; Ryu JH; Noh EJ; Jeon SD; Lim JS
Biochem Pharmacol; 2008 Mar; 75(5):1054-64. PubMed ID: 18054895
[TBL] [Abstract][Full Text] [Related]
24. Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation.
Wu GJ; Chen TL; Ueng YF; Chen RM
Toxicol Appl Pharmacol; 2008 Apr; 228(1):105-13. PubMed ID: 18191973
[TBL] [Abstract][Full Text] [Related]
25. MAP kinase-dependent, NF-kappaB-independent regulation of inhibitor of apoptosis protein genes by TNF-alpha.
Furusu A; Nakayama K; Xu Q; Konta T; Kitamura M
J Cell Physiol; 2007 Mar; 210(3):703-10. PubMed ID: 17133355
[TBL] [Abstract][Full Text] [Related]
26. 'Reverse' alpha-ketoamide-based p38 MAP kinase inhibitors.
Montalban AG; Boman E; Chang CD; Ceide SC; Dahl R; Dalesandro D; Delaet NG; Erb E; Gibbs A; Kahl J; Kessler L; Lundström J; Miller S; Nakanishi H; Roberts E; Saiah E; Sullivan R; Wang Z; Larson CJ
Bioorg Med Chem Lett; 2008 Oct; 18(20):5456-9. PubMed ID: 18835164
[TBL] [Abstract][Full Text] [Related]
27. Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: synthesis and SAR studies.
Lin X; Murray JM; Rico AC; Wang MX; Chu DT; Zhou Y; Del Rosario M; Kaufman S; Ma S; Fang E; Crawford K; Jefferson AB
Bioorg Med Chem Lett; 2006 Aug; 16(16):4163-8. PubMed ID: 16765046
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, crystal structure, and activity of pyrazole-based inhibitors of p38 kinase.
Graneto MJ; Kurumbail RG; Vazquez ML; Shieh HS; Pawlitz JL; Williams JM; Stallings WC; Geng L; Naraian AS; Koszyk FJ; Stealey MA; Xu XD; Weier RM; Hanson GJ; Mourey RJ; Compton RP; Mnich SJ; Anderson GD; Monahan JB; Devraj R
J Med Chem; 2007 Nov; 50(23):5712-9. PubMed ID: 17948975
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase.
Kim DK; Lim JH; Lee JA; Dewang PM
Bioorg Med Chem Lett; 2008 Jul; 18(14):4006-10. PubMed ID: 18571921
[TBL] [Abstract][Full Text] [Related]
30. Biphenyl amide p38 kinase inhibitors 1: Discovery and binding mode.
Angell RM; Bamborough P; Cleasby A; Cockerill SG; Jones KL; Mooney CJ; Somers DO; Walker AL
Bioorg Med Chem Lett; 2008 Jan; 18(1):318-23. PubMed ID: 18006306
[TBL] [Abstract][Full Text] [Related]
31. CEL-I, an invertebrate N-acetylgalactosamine-specific C-type lectin, induces TNF-alpha and G-CSF production by mouse macrophage cell line RAW264.7 cells.
Yamanishi T; Yamamoto Y; Hatakeyama T; Yamaguchi K; Oda T
J Biochem; 2007 Nov; 142(5):587-95. PubMed ID: 17846063
[TBL] [Abstract][Full Text] [Related]
32. Mitogen-activated protein kinases are involved in tumor necrosis factor alpha production in macrophages infected with Orientia tsutsugamushi.
Yun JH; Koo JE; Koh YS
Microbiol Immunol; 2009 Jun; 53(6):349-55. PubMed ID: 19493203
[TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical development.
McClure KF; Letavic MA; Kalgutkar AS; Gabel CA; Audoly L; Barberia JT; Braganza JF; Carter D; Carty TJ; Cortina SR; Dombroski MA; Donahue KM; Elliott NC; Gibbons CP; Jordan CK; Kuperman AV; Labasi JM; Laliberte RE; McCoy JM; Naiman BM; Nelson KL; Nguyen HT; Peese KM; Sweeney FJ; Taylor TJ; Trebino CE; Abramov YA; Laird ER; Volberg WA; Zhou J; Bach J; Lombardo F
Bioorg Med Chem Lett; 2006 Aug; 16(16):4339-44. PubMed ID: 16759861
[TBL] [Abstract][Full Text] [Related]
34. 3,5-Disubstituted quinolines as novel c-Jun N-terminal kinase inhibitors.
Jiang R; Duckett D; Chen W; Habel J; Ling YY; LoGrasso P; Kamenecka TM
Bioorg Med Chem Lett; 2007 Nov; 17(22):6378-82. PubMed ID: 17911023
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38alpha mitogen-activated protein kinase inhibitors.
Hynes J; Dyckman AJ; Lin S; Wrobleski ST; Wu H; Gillooly KM; Kanner SB; Lonial H; Loo D; McIntyre KW; Pitt S; Shen DR; Shuster DJ; Yang X; Zhang R; Behnia K; Zhang H; Marathe PH; Doweyko AM; Tokarski JS; Sack JS; Pokross M; Kiefer SE; Newitt JA; Barrish JC; Dodd J; Schieven GL; Leftheris K
J Med Chem; 2008 Jan; 51(1):4-16. PubMed ID: 18072718
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 Tat protein induces TNF-alpha and IL-10 production by human macrophages: differential implication of PKC-betaII and -delta isozymes and MAP kinases ERK1/2 and p38.
Leghmari K; Contreras X; Moureau C; Bahraoui E
Cell Immunol; 2008; 254(1):46-55. PubMed ID: 18692180
[TBL] [Abstract][Full Text] [Related]
37. Biphenyl amide p38 kinase inhibitors 2: Optimisation and SAR.
Angell RM; Angell TD; Bamborough P; Brown D; Brown M; Buckton JB; Cockerill SG; Edwards CD; Jones KL; Longstaff T; Smee PA; Smith KJ; Somers DO; Walker AL; Willson M
Bioorg Med Chem Lett; 2008 Jan; 18(1):324-8. PubMed ID: 17981461
[TBL] [Abstract][Full Text] [Related]
38. Prevotella intermedia lipopolysaccharide stimulates release of tumor necrosis factor-alpha through mitogen-activated protein kinase signaling pathways in monocyte-derived macrophages.
Kim SJ; Choi EY; Kim EG; Shin SH; Lee JY; Choi JI; Choi IS
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):407-13. PubMed ID: 17727652
[TBL] [Abstract][Full Text] [Related]
39. A novel lipid binding site formed by the MAP kinase insert in p38 alpha.
Diskin R; Engelberg D; Livnah O
J Mol Biol; 2008 Jan; 375(1):70-9. PubMed ID: 17999933
[TBL] [Abstract][Full Text] [Related]
40. Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity.
Hill RJ; Dabbagh K; Phippard D; Li C; Suttmann RT; Welch M; Papp E; Song KW; Chang KC; Leaffer D; Kim YN; Roberts RT; Zabka TS; Aud D; Dal Porto J; Manning AM; Peng SL; Goldstein DM; Wong BR
J Pharmacol Exp Ther; 2008 Dec; 327(3):610-9. PubMed ID: 18776065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
